ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting [clear]
Client Age
Topic Area
Experience
Course Format
SIG [clear]
Instructional Level
Results 11 - 15 of 15
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: It is well known within our field that identifying voice and upper airway specialized training opportunities and subsequent positions is challenging, competitive, and sometimes elusive. In this SIG 3 activity, various pathways to specializing in voice and upper airway disorders are explored from the viewpoint of different authors at various stages of their careers. The hope is to make the process of specialization more transparent and share components that have contributed to success, while also highlighting the diversity of training and experience that is so important in our field.
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course examines three progressive cultural topics as they relate to speech-language pathology and audiology: ageism among CSD graduate students; institutional, symbolic, and individual systems of oppression; and the interaction between social determinants and health disparities.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: Three clinical practice considerations are reviewed within this course, including communication with patients/families in the face of the COVID-19 pandemic, identification of word finding errors in normally aging individuals, and how to address severe tinnitus.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: The theme for this SIG 14 activity is clinical considerations through paradigm shifts in providing culturally relevant family-centered intervention and instruction. Topics include (a) providing culturally relevant family centered care; (b) second language literacy instruction for multilingual adolescents; and (c) impacts of study abroad experiences on students’ intercultural competence.
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted.
<< 1 2 > >>